FLASHDOSE
Table of contents:
| Trademark domain | |
| name | is free? |
|---|---|
| flashdose.com |  |
The "FLASHDOSE" trademark, serial number 78543928 , was filed on 7th of January 2005 with a mark drawing code of 4000 and its transaction date is 78543928. The attorney assigned is James R. Menker, attorney docket number 1001.0024. Since 14th of October 2010, the document can be found in the M20 law office in the publication and issue section. The employee responsible is REIHNER, DAVID C and the date it was published for opposition on 05/02/2006. The status of this trademark was checked last on 08/24/2009.
Prior registrations: 2048066
Other trademarks by this attorney include , WORLD CUP 2014 , SANTO PECADO . The corresponded responsible for this trademark is James R. Menker, located at Holley & Menker, P.A., PO Box 331937, Atlantic Beach FL 32233.The state or country where the trademark was organized is by Biovail Laboratories International Srl. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at Welches, Christ Church, zip BB17154 and also by Biovail Laboratories, Inc. - Corporation, located at Chelston Park Building 2, Ground Floor, Collymore, St. Michael, zip .Other trademarks by this applicant: ZILERAN.
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 01/19/2005 |
| Primary Code | 005 |
| Goods codes | |
| GS0051 | Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan |
| PM0000 | FLASH DOSE |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 09/29/2007 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 09/14/2007 | EXTENSION 2 GRANTED | S | EX2G - EXTENSION 2 GRANTED | |
| 07/12/2007 | EXTENSION 2 FILED | S | EXT2 - EXTENSION 2 FILED | |
| 10/13/2010 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | I - Incoming Correspondence | ASCK | |
| 08/24/2009 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | O - Outgoing Correspondence | MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | |
| 08/24/2009 | ABANDONMENT - NO USE STATEMENT FILED | S | ABN6 - ABANDONMENT - NO USE STATEMENT FILED | |
| 06/17/2009 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | I - Incoming Correspondence | ASCK | |
| 02/05/2009 | EXTENSION 5 GRANTED | S | EX5G - EXTENSION 5 GRANTED | |
| 01/22/2009 | EXTENSION 5 FILED | S | EXT5 - EXTENSION 5 FILED | |
| 02/05/2009 | CASE ASSIGNED TO INTENT TO USE PARALEGAL | A - Allowance for Publication | AITU | |
| 01/22/2009 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 01/22/2009 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | I - Incoming Correspondence | CHAN - APPLICANT CHANGES (NON-RESPONSIVE) ENTERED | |
| 01/22/2009 | TEAS CHANGE OF OWNER ADDRESS RECEIVED | I - Incoming Correspondence | COAR - TEAS CHANGE OF OWNER ADDRESS RECEIVED | |
| 07/17/2008 | EXTENSION 4 GRANTED | S | EX4G - EXTENSION 4 GRANTED | |
| 07/17/2008 | EXTENSION 4 FILED | S | EXT4 - EXTENSION 4 FILED | |
| 07/17/2008 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 02/07/2008 | EXTENSION 3 GRANTED | S | EX3G - EXTENSION 3 GRANTED | |
| 01/18/2008 | EXTENSION 3 FILED | S | EXT3 - EXTENSION 3 FILED | |
| 01/18/2008 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 07/12/2007 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 12/27/2006 | EXTENSION 1 GRANTED | S | EX1G - EXTENSION 1 GRANTED | |
| 11/09/2006 | EXTENSION 1 FILED | S | EXT1 - EXTENSION 1 FILED | |
| 11/09/2006 | TEAS EXTENSION RECEIVED | I - Incoming Correspondence | EEXT - TEAS EXTENSION RECEIVED | |
| 07/25/2006 | NOA MAILED - SOU REQUIRED FROM APPLICANT | O - Outgoing Correspondence | NOAM - NOTICE OF ALLOWANCE-MAILED | |
| 05/02/2006 | PUBLISHED FOR OPPOSITION | A - Allowance for Publication | PUBO - PUBLISHED FOR OPPOSITION | |
| 04/12/2006 | NOTICE OF PUBLICATION | O - Outgoing Correspondence | NPUB - NOTICE OF PUBLICATION | |
| 03/14/2006 | LAW OFFICE PUBLICATION REVIEW COMPLETED | O - Outgoing Correspondence | PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED | |
| 03/10/2006 | ASSIGNED TO LIE | A - Allowance for Publication | ALIE - ASSIGNED TO LIE | |
| 03/08/2006 | APPROVED FOR PUB - PRINCIPAL REGISTER | P | CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER | |
| 03/03/2006 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 02/09/2006 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 02/09/2006 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 08/09/2005 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
| 08/09/2005 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 08/09/2005 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 04/13/2005 | TEAS CHANGE OF CORRESPONDENCE RECEIVED | I - Incoming Correspondence | TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED | |
| 01/19/2005 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
The "FLASHDOSE" trademark, serial number 77789291 , was filed on 24th of July 2009 with a mark drawing code of 4000 and its transaction date is 77789291. The attorney assigned is James R. Menker, attorney docket number 1001.0120. Since 27th of April 2010, the document can be found in the L90 law office in the publication and issue section. The date when we last checked the status of this trademark was 04/27/2010.
Other trademarks by this attorney include , WORLD CUP 2014 , SANTO PECADO . The corresponded responsible for this trademark is JAMES R. MENKER, located at HOLLEY & MENKER, P.A., PO BOX 331937, ATLANTIC BEACH, FL 32233.The state or country where the trademark was organized is by Biovail Laboratories International Srl. The legal entity type behing it is a Other (Indicates Entity-Statement should appear)., located at Welches, Christ Church, zip BB17154.
| GOODS AND/OR SERVICES | |
| International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. | |
|---|---|
| U.S. Class | 052 - Detergents and Soaps |
| Class Status | 6 - Active |
| Status Date | 07/28/2009 |
| Primary Code | 005 |
| Goods codes | |
| GS0051 | Pharmaceuticals including pharmaceuticals for the prevention, treatment and alleviation of conditions, disorders, diseases and ailments of the central nervous system; Pharmaceutical preparations and substances including pharmaceutical preparations and substances for the prevention, treatment and alleviation of conditions, disorders, diseases and ailments of the central nervous system; Drug delivery agents consisting of rapidly dissolving compounds, formulations, compositions and agents that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical preparations in the nature of an oral drug delivery dosage system for the controlled release of pharmaceuticals ingredients |
| PM0000 | FLASH DOSE |
| PROSECUTION HISTORY | ||||
| Date | Description | Type | Code | |
|---|---|---|---|---|
| 04/27/2010 | TEAS/EMAIL CORRESPONDENCE ENTERED | I - Incoming Correspondence | TEME - TEAS/EMAIL CORRESPONDENCE ENTERED | |
| 04/27/2010 | CORRESPONDENCE RECEIVED IN LAW OFFICE | I - Incoming Correspondence | CRFA - CORRESPONDENCE RECEIVED IN LAW OFFICE | |
| 04/27/2010 | TEAS RESPONSE TO OFFICE ACTION RECEIVED | I - Incoming Correspondence | TROA - TEAS RESPONSE TO OFFICE ACTION RECEIVED | |
| 10/27/2009 | NOTIFICATION OF NON-FINAL ACTION E-MAILED | O - Outgoing Correspondence | GNRN | |
| 10/27/2009 | NON-FINAL ACTION E-MAILED | F - First Action | GNRT - NON-FINAL ACTION E-MAILED | |
| 10/27/2009 | NON-FINAL ACTION WRITTEN | R - Renewal | CNRT - NON-FINAL ACTION WRITTEN | |
| 10/27/2009 | ASSIGNED TO EXAMINER | D - Assigned to Examiner | DOCK - ASSIGNED TO EXAMINER | |
| 07/29/2009 | NOTICE OF PSEUDO MARK MAILED | O - Outgoing Correspondence | MPMK | |
| 07/28/2009 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | I - Incoming Correspondence | NWOS | |
| 07/28/2009 | NEW APPLICATION ENTERED IN TRAM | I - Incoming Correspondence | NWAP - NEW APPLICATION ENTERED IN TRAM | |
Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.
Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.